![Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire](https://mms.businesswire.com/media/20220624005275/es/739014/22/teva_RGB_JPEG.jpg)
Teva anuncia resultados provisionales prometedores de su estudio PEARL sobre el impacto de AJOVY® (fremanezumab) | Business Wire
![Know-how v. Patents, Prior User Rights Provisions, and Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.” | ZBM Patents & Trademarks Know-how v. Patents, Prior User Rights Provisions, and Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.” | ZBM Patents & Trademarks](https://www.zbm-patents.eu/2019/wp-content/uploads/2019/03/zea209.jpg)
Know-how v. Patents, Prior User Rights Provisions, and Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.” | ZBM Patents & Trademarks
![Roche Pharma China partners with Teva Pharmaceuticals to improve lymphoma treatments - Chinadaily.com.cn Roche Pharma China partners with Teva Pharmaceuticals to improve lymphoma treatments - Chinadaily.com.cn](https://img2.chinadaily.com.cn/images/202204/19/625e789aa310fd2bec83f401.jpeg)
Roche Pharma China partners with Teva Pharmaceuticals to improve lymphoma treatments - Chinadaily.com.cn
![Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com](https://images.law.com/contrib/content/uploads/sites/292/2022/11/Teva-767x633.jpg)
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
IONTAS anuncia un nuevo acuerdo de optimización de anticuerpos con Teva Pharmaceuticals | Technology Networks
![Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/03/recallTeva-700x547.jpg)